首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 醫療設備 > 病患監測 > 歐洲心血管裝置市場的動向:投資分析與成長機會
產業/市場分類
醫療設備 (3973)
內視鏡檢查設備 (115)
分子呈像/呈影劑 (29)
心血管設備 (244)
可拋式醫學設備 (83)
核子醫學 (75)
病患監測 (339)
眼科設備 (99)
傷口護理 (87)
超音波 (49)
齒科設備 (172)
導管 (199)
整形外科 (332)
醫學影像診斷 (399)
體外診斷設備 (386)
CT/MRI/X光 (142)
e保健 (309)
市場調查報告書

歐洲心血管裝置市場的動向:投資分析與成長機會

European Cardiovascular Devices Markets - Investment Analysis and Growth Opportunities (Financial Benchmarking & Analysis)

出版商 Frost & Sullivan
出版日期 2006年07月 商品編碼 42573
內容資訊 英文 93 pages
價格
US $ 4950 Web Access (Regional License)
US $ 5450 Hard Copy & Web Access (Regional License)


歐洲心血管裝置市場的動向:投資分析與成長機會 是由出版商Frost & Sullivan在2006年07月所出版的。 這份英文市場調查報告書包含93 pages 價格從美金4950起跳。

簡介

歐洲心血管裝置市場主要是由全球性企業所控制,市場內也頻繁地進行企業的收購案。市場主要業者是以透過收購小規模企業以補足其製品通路的方式來獲取市場成長的機會。

專門於高科技領域之顧問服務與市場調查的美國市調公司 Frost & Sullivan (總公司:美國德州),調查與分析歐洲心血管裝置市場,並有系統地出版綜合報告書 "European Cardiovascular Devices Markets - Investment Analysis and Growth Opportunities (Financial Benchmarking & Analysis)"

此報告書在下面的內容裡,除了說明歐洲心血管裝置市場的獲利與產業動向,也探討超過50家企業的成長監控器、過去5年內的企業收購合併動向等。

第1章 摘要

第2章 介紹

  • 介紹
  • 方法論

第3章 投資分析與成長機會

  • 市場概要
    • 心律管理
    • 侵入式心臟學
    • 心臟手術
    • 各國分析
  • 產業動向
  • 投資分析與成長機會
    • 投資主題
    • 價值鏈分析
    • 區域計分卡
    • 企業投資機會計分卡
    • Frost & Sullivan的心血管裝置成長監控器

第4章 財務基準與評價

  • Frost & Sullivan的心血管裝置分析
    • 產業分類
  • 比率分析
    • 年度銷售額成長
    • 營業獲利
    • 販賣費及一般管理費
    • 研究開發費
    • 員工每人的獲利
    • 平均資產回收率 vs. 平均股份投資回收率
    • 設備投資費
    • 流動比率
    • 入金及支付日
    • 存貨週轉率
    • 運用資本比率
    • 資產週轉率
  • 共通型分析
  • 固定費分析
  • 評價
    • 基於銷售及獲利的每年評價
    • 過去1年內的庫存狀況
    • 產業成長預測
    • EPS影響分析
    • 未公開股份及創業投資活動
  • 合併收購

圖表

目錄

Abstract

Frost & Sullivan's Medical Devices Financial Benchmarking and Analysis (FBA) service presents a broad financial outline of the medical devices industry, highlighting major market and financial trends in key growth segments. It provides a comprehensive financial analysis of leading medical devices firms to support the investment and financial analysis needs of decision makers in the marketplace. The current study within the service focuses on the following key growth sectors of the European Cardiology Devices Market:Cardiac Rhythm Management, Interventional Cardiology, and Cardiac Surgery.

Opportunities in potential investments lie ahead in Europe for venture capitalists

There is an abundance of ideas for innovation in Europe, though the continent lacks when it comes to commercialization of ideas into products.However,this scenario is slowly changing.In order to make Europe more competitive and innovation friendly, the European Medical Technology Industry Association (Eucomed) has proposed ten recommendations in 2005 to augment medical technology innovation in Europe.This 'innovation friendly' climate is expected to lend support and unfold several opportunities for novel ideas and devices thus presenting potential investment opportunities for venture capitalists.The study aims to analyze these potential investment opportunities present in the cardiovascular devices space and identify segments in the market that are attractive to private equity participants, institutional investors, and trade investors.

Cardiovascular device companies spring new interest in cardiac rhythm management

The European cardiovascular devices market is highly consolidated, being controlled by global players such as Boston Scientific, Johnson & Johnson, Medtronic, Sorin, and St. Jude Medical.With the acquisition of Guidant, by Boston Scientific, the space is only condensing further.Key market participants are constantly scouting for growth opportunities by acquiring smaller companies to fill in their R&D product pipelines.Companies targeted include those that develop technologies catering to an unmet need or that convert a surgery from an inpatient to an outpatient setting.Additionally, devices in the cardiac rhythm management specialty are also witnessing increased interest by large cardiovascular device companies.Johnson & Johnson, whose presence in the cardiac market so far has been confined to the segments of interventional cardiology and cardiac surgery, is now eyeing for an opportunity in the cardiac rhythm management space.Such aggressive acquisition onpart of bigger companies present attractive exit opportunities to venture capitalists in the form of a trade sale.

Table of Contents

1. Executive Summary

  • 1. Executive Summary
    • 1. Executive Summary

2. Introduction and Methodology

  • 1. Introduction
    • 1. Introduction
  • 2. Methodology
    • 1. Methodology

3. Investment Analysis and Growth Opportunities

  • 1. Market Overview
    • 1. Cardiac Rhythm Management
    • 2. Interventional Cardiology
    • 3. Cardiac Surgery
    • 4. Country Analysis
  • 2. Industry Economics
    • 1. Industry Economics
  • 3. Investment Analysis and Growth Opportunity
    • 1. Investment Themes
    • 2. Value Chain Analysis
    • 3. Sector Scorecard
    • 4. Company Investment Opportunity Scorecard
    • 5. Frost & Sullivan Cardiovascular Devices Growth Monitor

4. Financial Benchmarking and Valuation

  • 1. Frost & Sullivan Cardiovascular Devices Universe
    • 1. Industry Classification
  • 2. Ratio Analysis
    • 1. Year-over-Year Sales Growth
    • 2. Operating Margin
    • 3. Selling General and Administrative Expenses (SGA) to Sales
    • 4. Research and Development (R&D) to Sales
    • 5. Revenues per Employee
    • 6. Return on Average Assets versus Return on Average Equity
    • 7. Capital Expenditure to Sales
    • 8. Current Ratio
    • 9. Receivable and Payable Days
    • 10. Inventory Turnover Ratio
    • 11. Working Capital Ratio
    • 12. Asset Turnover Ratio
  • 3. Common Size Analysis
    • 1. Common Size Analysis
  • 4. Fixed Cost Analysis
    • 1. Fixed Cost Analysis
  • 5. Valuations
    • 1. Historical Valuations based on Sales and Profitability
    • 2. Year-to-Date Stock Performance
    • 3. Industry Growth Outlook
    • 4. EPS Impact Analysis
    • 5. Private Equity and Venture Capital Activity
  • 6. Mergers and Acquisitions
    • 1. Mergers and Acquisitionsa
Back to Top